Oncotelic Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Oncotelic Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2019 to Q3 2024.
  • Oncotelic Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2024 was 407M shares, a 2.39% increase year-over-year.
  • Oncotelic Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 396M shares, a 3.15% increase from 2022.
  • Oncotelic Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 384M shares, a 26.7% increase from 2021.
  • Oncotelic Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 303M shares, a 244% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 407M +9.51M +2.39% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-19
Q2 2024 402M +7.22M +1.83% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-14
Q1 2024 399M +7.02M +1.79% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 396M +12.1M +3.15% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-12
Q3 2023 398M +11M +2.85% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-19
Q2 2023 394M +15.2M +4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-14
Q1 2023 392M +15M +3.97% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 384M +81M +26.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-12
Q3 2022 387M +16.3M +4.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 379M +9.66M +2.61% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-18
Q1 2022 377M +283M +301% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-22
Q4 2021 303M Oct 1, 2021 Dec 31, 2021 10-K/A 2023-04-20
Q3 2021 370M +281M +316% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-18
Q2 2021 370M +281M +319% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-22
Q1 2021 94.2M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-23
Q3 2020 89M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-22
Q2 2020 88.2M +22.8M +34.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-20
Q2 2019 65.4M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.